6533b874fe1ef96bd12d6246

RESEARCH PRODUCT

Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalon.

María ÁNgeles Gómez-climentEmilio VareaJuan NacherF.j. Martínez-guijarroJ.m. Blasco-ibáñezCarlos CrespoEsther Castillo-gómez

subject

MaleTelencephalonNeuropilNeuriteSynaptophysinHippocampusPrefrontal CortexNeural Cell Adhesion Molecule L1AmygdalaHippocampusRats Sprague-DawleyAnimal models of depressionFluoxetinemedicineAnimalsPharmacology (medical)Prefrontal cortexBiological PsychiatryPharmacologyNeuronal PlasticitybiologyCerebrumAmygdalaImmunohistochemistryAntidepressive AgentsRatsPsychiatry and Mental healthmedicine.anatomical_structurePhenotypenervous systemNeurologySynaptophysinbiology.proteinSialic AcidsAntidepressive Agents Second-GenerationNeural cell adhesion moleculeNeurology (clinical)Neuroscience

description

Structural modifications occur in the brain of severely depressed patients and they can be reversed by antidepressant treatment. Some of these changes do not occur in the same direction in different regions, such as the medial prefrontal cortex, the hippocampus or the amygdala. Differential structural plasticity also occurs in animal models of depression and it is also prevented by antidepressants. In order to know whether chronic fluoxetine treatment induces differential neuronal structural plasticity in rats, we have analyzed the expression of synaptophysin, a protein considered a marker of synaptic density, and the expression of the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), a molecule involved in neurite and synaptic remodeling. Chronic fluoxetine treatment increases synaptophysin and PSA-NCAM expression in the medial prefrontal cortex and decreases them in the amygdala. The expression of these molecules is also affected in the entorhinal, the visual and the somatosensory cortices.

10.1016/j.euroneuro.2007.01.001https://pubmed.ncbi.nlm.nih.gov/17307340